project id: TCGA-LUAD; case submitter id: TCGA-95-7948; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; age at index: 42; days to birth: -15363; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1969; age at diagnosis: 15363; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IB; ajcc pathologic t: T2a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 476.0; icd 10 code: C34.3; last known disease status: not reported; morphology: 8255/3; primary diagnosis: Adenocarcinoma with mixed subtypes; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower lobe, lung; synchronous malignancy: Not Reported; tissue or organ of origin: Lower lobe, lung; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 0.00821917808219178; pack years smoked: 0.15; years smoked: 2.0; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.7; longest dimension: 1.3; oct embedded: No; shortest dimension: 0.3; portion submitter id: TCGA-95-7948-01A-11; percent lymphocyte infiltration: 20.0; percent monocyte infiltration: 5.0; percent necrosis: 0.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 19.0; percent tumor cells: 81.0; percent tumor nuclei: 71.0;